TrialDrug safety2022

Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies.

Giulio Barteselli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.